Boohoo shares surge after first return to growth in years as turnaround gains traction
Boohoo reports first quarterly growth in years as Debenhams and PrettyLittleThing drive recovery momentum rise.
Boohoo reports first quarterly growth in years as Debenhams and PrettyLittleThing drive recovery momentum rise.
B&M profit halves after tough year as UK sales stabilise and shares surge sharply higher.
Shares fall as oil prices jump amid Middle East tensions and renewed US Iran clashes
BATS drops on lower-end guidance and combustible share losses despite smokeless products momentum.
London shares rise modestly as miners gain, AI enthusiasm lifts global markets amid Middle East uncertainty.
Marks and Spencer’s cyber attack scarred last year’s numbers, but the underlying business looks stronger than the current share price implies.
Avacta files AIM block listing for employee share schemes as AVA6000 delivers strong ASCO results.
FTSE 100 falls as Iran suspends US talks, lifting oil prices and energy stocks.
Wise shares fall sharply after Belgian money laundering probe is publicly revealed today.
SE beat expectations, raised its dividend and investment plans, but shares fell as valuation concerns dominated.
Ocado secured a major Asda partnership, lifting shares after setbacks hit its warehouse technology operations recently.
FTSE 100 dips as Trump weighs Iran peace decision, sending oil prices sharply lower globally.
Israeli hotel giant Fattal tables £22-per-share cash offer for FTSE 250 hospitality group.
London stocks retreated as renewed Middle East violence unsettled investors despite reports of diplomatic progress emerging.
SSE reports earnings at guidance top end, 7% dividend rise, record £3.6bn capex investment.
Pets at Home shares rally on genuine retail progress, yet at 199.80p the market is underpricing the risk that stabilisation proves temporary.
FTSE 100 edges sideways as Middle East tensions, oil swings and corporate updates shape sentiment.
Pets At Home profits fell sharply after weak retail demand, despite improving sales momentum and veterinary growth.
Hollywood Bowl lifted its dividend and launched a £5 million buyback after stronger interim trading.
FTSE 100 closes higher as BP slump offsets gains from miners and retailers.
easyJet shares down 26% YTD despite strong holidays growth and improved load factors.
B&Q owner Kingfisher surges after confident Q1 update, confirming full-year profit guidance despite weak seasonal demand.
Bodycote surges on Apollo’s takeover proposal, valuing the British heat treatment firm at £1.52 billion.
FTSE 100 rose to 10,466 as Games Workshop and FTSE 250 stocks surge on bid interest and upgrades.
Ceres Power rallies on reported UBS price target lift.
Games Workshop forecasts record revenues driven by miniatures sales momentum and store expansion.
Rolls-Royce shares are up 85% in a year, but with valuations near record highs, expectations now leave little room for mistakes.
AJ Bell beats expectations with record inflows, 19% revenue growth and upgraded profit outlook.
FTSE 100 closes higher as miners rally, earnings disappoint and oil climbs again.
Record Experian results and a $1bn buyback fail to lift shares amid AI disruption fears.
Cooler inflation and a busy results day push the FTSE 100 up 0.94%.
M&S beats profit forecasts and raises dividend, signalling recovery from devastating cyberattack.
IG Group’s shares hit a record high after a strong Q1 trading update lifted guidance.
Currys jumps 14% after raising full-year profit guidance to £191 million, ahead of previous estimates.
3i Group delivered 22% returns and 19% NAV growth, yet shares fell 17% on results day after Action’s like-for-like sales growth halved.
Big Yellow revenue edges up 2% but pretax profit falls 38% as geopolitical pressures bite hard.
The FTSE 100 rose 1.26% to 10,323.75 on Monday as oil strength offset UK political turmoil and elevated bond yields.
Barclays combines strong capital returns, resilient trading income and cheap valuation, though rising impairments remain an uncomfortable warning signal.
NatWest’s Q1 impairment spike and weaker macro outlook expose margin pressure, making the pricey Evelyn deal harder to justify in a slowdown.
Strong FY26 results and German recovery show promise, but stretched valuation and analyst caution suggest gains may already be priced in.